IP Library Patent Application 13210302
Patent Application
App. No. 13/210,302

METHODS FOR IDENTIFICATION OF NOVEL PROTEIN DRUG TARGETS AND BIOMARKERS UTILIZING FUNCTIONAL NETWORKS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/210,302
Abstract

The process of System Reconstruction is used to integrate sequence data, clinical data, experimental data, and literature into functional models of disease pathways. System Reconstruction models serve as informational skeletons for integrating various types of high-throughput data. The present invention provides the first metabolic reconstruction study of a eukaryotic organism based solely on expressed sequence tag (EST) data. System Reconstruction also provides a method for the identification of novel therapeutic targets and biomarkers using network analysis. The initial seed networks are built from the lists of novel targets for diseases with the high-throughput experimental data being superimposed on the seed networks to identify specific targets.

Claims (6)

1 . A method for identifying drug or gene therapy targets comprising:

a) collecting data regarding an organism's metabolism for both non-disease and disease states;

b) linking the data into metabolic pathways;

c) identifying the interconnections between the metabolic pathways;

d) creating a map of the organism's metabolism by integrating information obtained in a), b) and c); and

e) identifying drug targets by comparing differences between non-disease and disease states using the map.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2012
From: NIKOLSKAYA, TATIANA; BUGRIM, ANDREJ; NIKOLSKY, YURI
To: GENEGO, INC.
Reel/Frame 028819/0982 →